Needham & Company Maintains a 'Hold' on Obagi Medical Products (OMPI); Strong Start, But Valuation Keeps Us Sidelined

Go back to Needham & Company Maintains a 'Hold' on Obagi Medical Products (OMPI); Strong Start, But Valuation Keeps Us Sidelined